Increasing evidence suggests that neuropeptides play a role in the regulatory mechanisms between the neuroendocrine and immune systems. A differential expression of the 5 known somatostatin (SS) receptors (sst [1][2][3][4][5] ) has been demonstrated in human immune cells and tissues.
Introduction
Somatostatin-14 and somatostatin-28 are 14-and 28-amino acid neuropeptides, which are mainly produced in the central nervous system, gastro-intestinal tract and endocrine glands (40, 41) . In these systems somatostatin (SS) has a predominant inhibitory action, especially with regard to the release of mediators, such as hormones (12, 13, 36) . SS acts via G-protein coupled seven transmembrane receptors of which 5 different subtypes have been cloned, named sst 1-5 (35) . In addition to their role in endocrine tissues, it is hypothesized that neuropeptides might play a regulatory role in the human immune system as well (30, 32, 48) .
As a neuropeptide, a role in the immune system might be ascribed to SS and its receptors (30).
In contrast to the human immune system, the role of SS and its receptors has been extensively studied in granulomas induced by Schistosoma Mansoni infection in the murine immune system (57). Murine T-lymphocytes selectively expressed sst 2 (11) and macrophages expressed SS mRNA (56). Treatment of Schistosoma Mansoni infected mice with SS resulted in granuloma growth inhibition (24) . Following these studies in the murine immune system, the question was addressed whether SS and sst might play a regulatory role in cells of the human immune system as well. Monocytes and its functionally derived cells, i.e. macrophages and dendritic cells are important components in different pathways in the human immune system.
They play important roles in inflammatory responses by production of both pro-inflammatory and immunosuppressive cytokines, antigen-presentation and phagocytosis (8, 17, 29, 54) .
Previous studies have demonstrated binding sites for SS on lymphocytes and monocytes (9, 10) suggesting a role for sst in these cells of the human immune system.
Immunohistochemistry studies showed that CD68-positive macrophages in human sarcoid granulomas expressed sst 2 (50). Equivocal studies have reported on functions of SS on cells of the monocyte lineage. Both inhibitory (7, 38) and stimulatory (28) effects have been described on cytokine production by macrophages. SS increased cytotoxicity of macrophages against tumour cells as well (37) , and SS can act as an antiangiogenic factor by inhibiting endothelial cell growth and monocyte migration (4). However, little is known about the expression and regulation of the different sst subtypes in cells of the monocyte-lineage, i.e. monocytes, macrophages and dendritic cells. Moreover, it is not known whether the natural ligand for the sst, e.g. SS, is expressed itself in cells of the monocyte lineage.
Therefore, we investigated in the present study mRNA expression of sst [1] [2] [3] [4] [5] and SS in monocytes and monocyte-derived macrophages and -dendritic cells. Moreover, we investigated the regulation of the expression of the mRNA encoding a SS-like peptide, cortistatin (CST), which was previously detected in cells and tissues from the human immune system (19) and binds with high affinity to all 5 sst (26), and which, therefore, might serve as an alternative ligand to sst. Sst and CST mRNA levels were studied in monocytes, macrophages and dendritic cells in both basal and lipopolysaccharide(LPS)-stimulated conditions using a TaqMan ® assay. In order to investigate possible regulation of mRNA levels, expression was measured from day 1 to 6 of differentiation of monocytes into both macrophages and dendritic cells. Expression of the sst protein on cell membranes of macrophages and dendritic cells was studied using FITC-labelled octreotate, a fluorescencelabelled sst 2 selective agonist, and visualized by confocal microscopy.
Material and methods

Isolation of blood mononuclear cells
Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats (Sanquin Blood bank, Rotterdam, The Netherlands) by Ficoll (Pharmacia, Uppsala, Sweden; density 1.077 g/ml) gradient centrifugation. Subsequently, monocytes were isolated from PBMC using a Percoll (Pharmacia; density 1.063 g/ml) density gradient centrifugation as described in detail previously (27) . Isolated monocytes were frozen in 10% DMSO-medium and stored in -80° C until use.
Cell-culture
A frozen suspension of monocytes was rapidly thawed in a water-bath at 37° C and viability was evaluated by Trypan-blue exclusion (Life Technologies, Grand Island, U.S.A.). Cell viability always exceeded 95%. Cells were seeded at a density of 0.5 x 10 6 cells/cm 2 in a volume of 1 ml/well in 24 well Nuncleon plates (Nalge Nunc International, Denmark) in RPMI1640+ supplemented with 10% heat-inactivated (30 min 56˚ C) fetal calf serum (FCS, Life Technologies, Grand Island, U.S.A.), L-glutamine (2 mM, Life Technologies) and penicillin (1000 U/ml, Yamanouchi Pharma BV Leiderdorp, The Netherlands). Plates were then incubated for 90 minutes at 37˚ C to allow adherence of the monocytes to the plate.
Thereafter, plates were washed to remove potential contaminating T-and B-cells. To generate macrophages, fresh medium was added, containing granulocyte macrophage-colony stimulating factor (GM-CSF, 500 U/ml, Novartis Pharma BV, Arnhem, The Netherlands).
The cells were cultured for 6 days, with medium refreshment at day 3. To generate dendritic cells, the isolated monocytes were incubated for 6 days with GM-CSF (500 U/ml) and IL-4
RT-PCR was performed as described previously (25). Briefly, poly A + mRNA was isolated using Dynabeads Oligo (dT) 25 (Dynal AS, Oslo, Norway) from tissue samples and cells.
cDNA was synthesized using the poly A + mRNA, which was eluted from the beads in 40 µl H 2 O for 10 minutes at 65 °C, using Oligo (dT) [12] [13] [14] [15] [16] [17] [18] Primer (Life Technologies). One-twentieth of the cDNA library was used for each amplification by PCR using primer sets specific for human SS, sst 1-5 , CST and hypoxantine-phosphoribosyl-transferase (HPRT) as a control (see Table 1 ). The primer set used to detect CST mRNA was adapted from Ejeskar et al. Netherlands). After an initial denaturation at 94°C for 5 minutes, the samples were subjected to 40 cycles of denaturation at 94° C for 1 min, annealing for 2 min at 60° C and extension for 1 min at 72° C. After a final extension for 10 min at 72° C, 10 µl aliquots of the resulting PCR products were analyzed by electrophoresis on 1.5% agarose gels stained with ethidiumbromide. The identity of the products was confirmed by direct sequencing using an ABI Prism TM 3100 Genetic Analyzer (Applied Biosystems) according to manufacturers protocol. 
Quantitative PCR
Visualization of sst 2 receptors on human macrophages
Monocytes were cultured for 6 days on round coverslips (Ø 24 mm, Omnilabo BV, The Netherlands) in the presence of GM-CSF to obtain macrophages, or in the presence of both octreotate-FITC, which binds to sst 2 selectively (43), in order to determine binding to sst 2 receptors and internalization of the receptor-ligand complex using confocal microscopy (LSM 410, Carl Zeiss Instruments, Jena, Germany). A 40X/1.4 numerical aperture objective lense was used. FITC was excited with a 488 nm Ar-laser and fluorescence emission was detected using a 515-540 nm bandpass filter. Images were typically taken at a 4x zoom. As a positive control, a stably sst 2 -transfected cell-line (CC2B) was used. In order to determine specificity of the binding of octreotate-FITC, binding was displaced by excess unlabelled octreotide.
Results
By FACS analysis the phenotypes of the isolated monocytes, cultured macrophages and dendritic cells were confirmed. In table 2 the mean percentages of positively stained cells are
shown. Monocytes showed low expression of CD80, compared to macrophages (at day 6) and dendritic cells (at day 6). CD80 is upregulated in macrophages, with a peak at day 3 of culture and declining thereafter, whereas expression of CD80 in dendritic cells was upregulated and remained stable (47). Dendritic cells express lower CD68, CD71 and CD86 compared to macrophages. This has been described previously (18) As a control, human thymic tissue was used, which expresses both SS and CST mRNA (figure 3). In order to evaluate the quantitative expression of the different mRNAs found by RT-PCR, Q-PCR was used for detection of sst 2 and CST mRNA levels. We detected relative low expression levels of sst 2 mRNA in cells under basal conditions (macrophages and dendritic cells showed an approx. 10-fold higher sst 2 mRNA expression compared to monocytes, p< 0.001), while sst 2 mRNA expression was significantly upregulated when cells were stimulated with 2 µg/ml LPS (figure 4). In experiments using increasing concentrations of LPS (range 10 ng/ml -2 µg/ml), 2 µg/ml LPS was shown to give maximal induction of sst 2 mRNA expression (data not shown). As shown, LPS induced an approx. 40-(p<0.0001), 200-(p<0.0001) and 20-fold (p<0.0001) increase in sst 2 expression in activated monocytes, macrophages and dendritic cells, respectively. Whereas RT-PCR demonstrated that SS mRNA was absent after stimulation of the cells with LPS, expression of the CST mRNA as possible alternative ligand for sst 2 in these cells, was upregulated upon LPS-activation (Table   3 ). CST mRNA was significantly upregulated by approximately 2-(p=0.002), 3-(p<0.0001) and 10-fold (p<0.0001) in activated monocytes, macrophages and dendritic cells, respectively.
To further investigate the upregulation of both sst 2 and CST mRNA by LPS stimulation in monocytes and mature macrophages and dendritic cells, expression and possible regulation of both mRNA levels were studied during differentiation of monocytes into its derived cells.
Cells were collected from day 1 to 6 of culture to measure sst 2 and CST mRNA levels. During differentiation of monocytes into macrophages and dendritic cells, cells were incubated without or with LPS for 24 hours at day 1, 2, 3, 4, 5 or 6 of culture. The expression levels of both sst 2 and CST mRNA were measured during this time-dependent differentiation of monocytes into macrophages and dendritic cells. In unstimulated differentiating cells, using Q-PCR, no expression of sst 2 mRNA could be detected in macrophages and dendritic cells until day 6 (data not shown). In the LPS-stimulation experiments, sst 2 mRNA expression was detected in dendritic cells only at day 5 (p<0.0001) and 6, whereas sst 2 mRNA expression in macrophages was low and relatively constant at day 1 to 4, with a significant increase at day 5 and 6 (P<0.0001 vs. day 4). This is shown in figure 5 . In contrast to the time-dependent basal sst 2 mRNA expression, we could detect sst 2 mRNA expression in LPS-stimulated macrophages at day 1 to 5 of culture, although it was very low. However, in LPS-stimulated dendritic cells, we could not detect sst 2 mRNA expression at day 1 to 4. This finding is in accordance with the much lower expression of sst 2 mRNA in dendritic cells in both basal (data not shown) and LPS-stimulated conditions (figure 5) when compared to macrophages and suggests that sst 2 mRNA expression levels in LPS-stimulated dendritic cells are below assay detection limitm, rather than dendritic cells do not respond to the LPS-stimulation. In unstimulated cells, expression of CST mRNA in macrophages increased after day 1 and reached its maximum already at day 2 (p=0.01) (figure 6). Dendritic cells showed maximal expression of CST mRNA already at day 1. LPS-induced CST mRNA expression during differentiation of macrophages was already maximal at day 1 of culture. In LPS-activated dendritic cells CST mRNA expression was low at day 1, 2 / 3 of maximum at day 2 (p<0.01) and reached its maximum at day 3 (figure 6, p<0.01 compared to CST mRNA expression at day 1).
In order to demonstrate that sst 2 receptors were actually expressed on the cultured cells, macrophages and dendritic cells were incubated with the FITC-labelled octreotate, and visualized using a LSM410 confocal laser microscope (Carl Zeiss, Jena, Germany). Treatment of Schistosoma infected mice with SS resulted in granuloma growth inhibition by decreasing the IFN-γ production by T-cells. Moreover, in rat lymphoid tissues SS is expressed (2) and rat T-and B-lymphocytes from the thymus and spleen synthesize and secrete SS (3).
In the human immune system, the role of SS and sst and the regulation of their expression remains still unclear. It is not known whether SS plays a regulatory role in the human immune system and whether this is comparable to the situation in the experimental rodent models.
Cells of the monocyte lineage, i.e. monocytes, macrophages and dendritic cells, are known to be an important component in the human immune system (8, 17, 29, 54) .
Therefore, in the present study we investigated by RT-PCR the expression and regulation of the mRNA levels encoding the 5 known sst and SS in cells of the human monocyte lineage.
We detected expression of only sst 2 mRNA in monocytes, macrophages and dendritic cells. In the present study we mainly focussed on the expression and regulation of the 5 sst in cells of the monocyte lineage. As shown, only the sst 2 mRNA could be detected by RT-PCR, in both activated and non-activated cells. A previous study showed that sst 2 expression in leukocytes was upregulated after PHA stimulation (52). In this study, however, the regulation of sst 2 expression in cells of the monocyte lineage was not addressed. To investigate this regulation, monocytes were cultured into macrophages or dendritic cells, as schematically shown in Figure 1 and expression levels of sst 2 mRNA were measured using Q-PCR. Under basal conditions, expression of sst 2 was very low. Macrophages and dendritic cells expressed approximately 10-fold higher sst 2 mRNA levels than monocytes. In LPS-stimulated cells, expression of sst 2 mRNA was significantly upregulated, suggesting a potential role of the sst 2 in more mature and activated cells. We demonstrated that sst 2 mRNA is upregulated relatively late during culture. In this respect the dramatic rise in sst 2 mRNA between day 4 and 5 of culture is obvious. We observed this dramatic rise during maturation of monocytes into dendritic cells, as well as into macrophages. Therefore, we hypothesize that sst 2 expression only reaches significant levels after full maturation of monocytes, irrespective of the direction of differentiation. In the murine immune system it has been demonstrated that sst 2 plays an important role in granuloma formation in Schistosoma infected mice and that SS treatment inhibited granuloma growth through binding to sst 2 on T-cells and subsequent decline of IFN-γ production by these T-cells (11, 24) . The question is now addressed whether sst 2 also plays a role in the human immune system. In previous studies sst 2 expression was detected in granulomatous diseases as sarcoid granulomas and rheumatoid arthritis (51, 53) . Recently, in a preliminary study 10 patients with rheumatoid arthritis have been treated with the longacting SS analogue, octreotide. Significant clinical improvement was found in these patients (33). In one study, 2 patients with sarcoidosis were treated with octreotide, a sst 2 -selective SSanalogue (50). One patient responded very well, while the second showed no clinical response. These results, in combination with the expression of sst in cells of the monocytelineage indicate that SS or its analogue octreotide might have clinical significance in diseases affecting the human immune system, acting via the sst 2 expressed macrophages or dendritic cells. As we demonstrated expression of sst 2 mRNA in cells of the monocyte lineage and no expression of SS mRNA itself, we also investigated the expression of the mRNA encoding CST, as a possible autocrine ligand for the sst 2 , which has been proposed for SS in the rodent immune system (11, 24, 56, 57) . As previously reported (19), we found CST mRNA expression in all cell samples. Therefore, we evaluated the regulation of CST mRNA during differentiation of monocytes and by LPS stimulation.
Monocytes showed low expression levels of CST mRNA, which were considerably upregulated in macrophages and dendritic cells. LPS-activation of these cells resulted in a significant upregulation of the CST mRNA levels as well. This upregulation during differentiation and by LPS activation suggests a possible role for CST in these human immune cells, especially in the mature cells and in cells in activated state. CST mRNA expression was also measured during differentiation of monocytes under basal and LPSstimulated conditions. Overall, CST mRNA expression was upregulated earlier during differentiation, both in basal and LPS-stimulated conditions, than sst 2 mRNA expression.
Whereas an autocrine SS-sst 2 regulatory pathway has been described in the murine immune system, the absence of SS and presence of CST mRNA suggests a more likely autocrine CST- Unfortunately, at this moment we are unable to detect the protein for CST in the cells expressing CST mRNA. However, the expression of the mRNA and moreover, the regulation of this expression during differentiation and by activation suggests that CST indeed may play a role in the human immune system. Further functional studies should be performed to elucidate the possible effects of CST on these cells.
In conclusion, we investigated the mRNA expression of the 5 known sst in cells of the monocyte lineage, as well as its endogenous ligand SS and an alternative ligand CST. In monocytes, macrophages and dendritic cells only expresion of sst 2 mRNA could be detected, whereas no SS mRNA was expressed. Interestingly, CST mRNA was expressed in all cells.
When cells were stimulated with LPS, sst 2 expression was upregulated significantly, pointing to a possible role of at least these receptors in the human immune system. These receptors might show interaction with CST in the immune system, but it is also possible that SS reaches the place of inflammation by nerve-endings, in which SS is produced. During differentiation of monocytes into macrophages and dendritic cells, both sst 2 and CST mRNA levels were upregulated as well, pointing to a more important role of the sst 2 -CST system in more mature cells. Interestingly, it seemed that CST mRNA was upregulated earlier during differentiation Results are the mean of three independent experiments using cells from three different healthy donors. Scale bar is 20 µm. 
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